Actively Recruiting
Transgender In Transition: Metabolism, Behaviour and Psychopathology in Transsexual Patients Following Hormonal Treatment
Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2022-11-08
750
Participants Needed
5
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the effects of gender-affirming hormone therapy on individuals diagnosed with gender incongruence or gender dysphoria. This observational study aims to understand the psychological, biological, and behavioral changes caused by hormone treatments. The focus is on how sex hormones influence mental health, metabolism, and behavior over long-term use. Participants in this study undergo hormone therapy while researchers collect data through various methods. These include clinical interviews, self-rating questionnaires, behavioral experiments using virtual reality and computer games, and genetic testing from blood, stool, hair, and saliva samples. The study uses online surveys at multiple timepoints before and up to 10 years after starting hormone therapy to monitor changes. During the study, participants complete psychometric assessments and behavioral tests to measure mental health, life satisfaction, sexual health, and other psychological traits. Researchers also track side effects and social support. The main outcome is assessed using the Mini International Neuropsychiatric Interview over a 10-year period. Participants contribute data through scheduled online surveys and clinical evaluations, helping to provide a comprehensive understanding of hormone therapy's long-term effects.
CONDITIONS
Brief Title
Transgender In Transition
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5)
- Written informed consent after receiving oral and written information
- Have not yet started gender-affirming hormonal treatment
- Age 18 years or older
You will not qualify if you...
- Pregnancy
- Breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants complete psychometric assessments and provide biological samples to evaluate psychological, metabolic, and behavioral parameters before and after hormone therapy.
14 online surveys at baseline and at 3, 6, 9, 12, 24, 36, 48, 60, 72, 84, 96, 108, and 120 months after hormonal therapy
Trial Site Locations
Total: 5 locations
1
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse, Germany, 60590
Not Yet Recruiting
2
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246
Actively Recruiting
3
Medical Center of the Ludwig-Maximilians-University of Munich
Munich, Germany
Not Yet Recruiting
4
Universitätsspital Basel
Basel, Switzerland, 4031
Not Yet Recruiting
5
UniversitätsSpital Zürich
Zurich, Switzerland, 8091
Not Yet Recruiting
Research Team
J
Johannes Fuß, MD
J
Johanna Schröder, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here